Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tempus is a public health technology and precision medicine company that applies artificial intelligence, multimodal data, and molecular diagnostics to improve clinical care and accelerate therapeutic development. The company is best known for its oncology-focused genomic testing, algorithmic diagnostics, clinical decision support, and real-world data products for providers, health systems, and life sciences partners. Tempus also offers sequencing, biomarker, and data services that support research, clinical development, commercialization, and trial enrollment. Beyond oncology, it has expanded into hereditary testing, cardiology, radiology, and neurology/psychiatry. Tempus operates as a commercial-stage platform company rather than a therapeutics developer, so its core value lies in diagnostics, software, and data infrastructure rather than a traditional drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tempus Technologies.